X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling
Rainer Döffinger(Hôpital Necker-Enfants Malades), Jean‐Laurent Casanova(Howard Hughes Medical Institute), Denis J. Headon(University of Edinburgh), Ralph Shapiro, Anne Durandy(Hôpital Necker-Enfants Malades), Mary Ellen Conley(St. Jude Children's Research Hospital), Dinakantha Kumararatne(Hôpital Necker-Enfants Malades), Arnold Münnich(Institut des Maladies Génétiques Imagine), Alain Fischer(Inserm), Asma Smahi(Délégation Paris 5), Gilles Courtois(Inserm), Christine Bessia(Centre National de la Recherche Scientifique), Paul A. Overbeek(Baylor College of Medicine), Sue Kenwrick(University of Cambridge), Steven M. Holland(National Institute of Allergy and Infectious Diseases), Christine Bodemer(Hôpital Necker-Enfants Malades), Hermann Kalhoff(Klinikum Dortmund), Kiran Belani, Frédéric Geissmann(Memorial Sloan Kettering Cancer Center), Mario Abinun(North Tyneside General Hospital), Alain Israël(Centre National de la Recherche Scientifique), Stéphane Blanche(Délégation Paris 5), Françoise Le Deist(Centre National de la Recherche Scientifique), Jacqueline Feinberg(Human Genetic of Infectious Diseases), Eric Reimund, Philip Wood(Heartlands Hospital), Sophie Dupuis‐Girod(Hospices Civils de Lyon)
Cited by 819
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k